Accumulating evidence has highlighted the significance of the cGAS-STING pathway in diverse hepatic disorders, including NAFLD, ALD, viral hepatitis, HIRI, C-DILI, Liver Neoplasms, Liver Cirrhosis, and Parasitic Liver Disease (12, 13, 45). This evidence concerns the gene CGAS and metabolic dysfunction-associated steatotic liver disease.